|
Real-time Estimate
Cboe BZX
21:29:18 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 10.36 USD | +0.34% |
|
+3.95% | +54.54% |
| 06:50pm | Novavax Earns $125 Million Milestone Payment From Sanofi's Phase 3 Vaccine Trial in Europe | MT |
| 10-19 | Shah Capital Ends Activist Push Against Novavax | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVAVAX, INC. | Other Biotechnology & Medical Research | +0.58% | +3.95% | +54.54% | +23.93% | -93.02% | 1.7B |  |  | |
- Stock Market
- Stocks
- NVAX Stock
- Charts Novavax, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
